For close to a decade, we’ve heard much about the promises of continuous manufacturing (CM) for oral solid dosage (OSD). So now that four OSD drugs are being manufactured by CM in the United States (at Vertex, Janssen, and Lilly), with at least five more in the approval pipeline, it’s time to take stock: Has CM delivered on its promises?
Choose Your Location
To customize your experience, select an IPS region or country to view specific information based on your location.
- United States
- All Other Countries
You’ve chosen as your location.
Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.